Drug profile · INN
cinacalcet hydrochloride
CINACALCET HYDROCHLORIDE
cinacalcet hydrochloride (CINACALCET HYDROCHLORIDE) is a calcium sensing receptor positive allosteric modulator. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — cinacalcet hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 0
- Data quality
- 0.89
Quick answer
cinacalcet hydrochloride (CINACALCET HYDROCHLORIDE) is a calcium sensing receptor positive allosteric modulator. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Calcium sensing receptor positive allosteric modulator
Primary target: Extracellular calcium-sensing receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is cinacalcet hydrochloride?
cinacalcet hydrochloride (CINACALCET HYDROCHLORIDE) is a calcium sensing receptor positive allosteric modulator. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cinacalcet hydrochloride?
CINACALCET HYDROCHLORIDE is a marketed brand name for cinacalcet hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cinacalcet hydrochloride?
cinacalcet hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.